Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

tags : Ev    source : Www.biospace.com    save search

ReCode Therapeutics Appoints Angèle Maki, Ph.D., as Senior Vice President of Business Development
Published: 2021-08-16 (Crawled : 13:00) - biospace.com/
LLY | News | $731.33 0.69% 0.0% 2.3M twitter stocktwits trandingview |
Health Technology
| | O: 0.33% H: 2.03% C: 1.91%

ev
LivaNova Announces Early Retirement of $450 Million Term Loan and Executes $125 Million Revolving Credit Facility
Published: 2021-08-16 (Crawled : 12:00) - biospace.com/
UBS | News J | $27.97 -0.32% 0.0% 3.4M twitter stocktwits trandingview |
Finance
| | O: -0.5% H: 0.5% C: 0.47%
LIVN | $54.005 3.2% 3.1% 710K twitter stocktwits trandingview |
Health Technology
| | O: -2.23% H: 3.25% C: 2.88%

ev
Longeveron to Release Second Quarter 2021 Financial Results and Hold Conference Call on August 13, 2021
Published: 2021-08-10 (Crawled : 13:00) - biospace.com/
LGVN 4 d | $1.92 0.0% 480K twitter stocktwits trandingview |
| | O: -0.85% H: 3.52% C: -2.56%

financial results results ev conference
Sierra Oncology Provides Update to Momelotinib Development Timeline and Closes on $34 Million in Additional Funding
Published: 2021-08-09 (Crawled : 12:15) - biospace.com/
SRRA | $54.99 0.04% 0.0% twitter stocktwits trandingview |
Health Technology
| | O: 4.96% H: 11.06% C: 7.83%

funding ev
Trevena to Release Second Quarter 2021 Financial Results on August 12th, 2021
Published: 2021-08-09 (Crawled : 12:00) - biospace.com/
TRVN | $0.374 6.25% 5.88% 420K twitter stocktwits trandingview |
Health Technology
| | O: 0.0% H: 4.23% C: -0.7%

financial results results ev
Surmodics Reports Third Quarter Fiscal 2021 Results and Updates Fiscal 2021 Revenue and EPS Guidance
Published: 2021-08-04 (Crawled : 13:00) - biospace.com/
SRDX | $25.32 -4.42% -4.62% 120K twitter stocktwits trandingview |
Health Technology
| | O: -1.19% H: 2.12% C: -1.74%

results ev
NRx Pharmaceuticals Partners with MannKind Corporation to Develop ZYESAMI™ (aviptadil) Inhaler for Respiratory Conditions
Published: 2021-08-04 (Crawled : 12:00) - biospace.com/
NRXP 5 d | $3.01 -0.99% -1.0% 210K twitter stocktwits trandingview |
Manufacturing
| | O: -0.62% H: 5.59% C: -7.91%
MNKD | $4.12 -1.44% -1.46% 1.8M twitter stocktwits trandingview |
Health Technology
| | O: 0.0% H: 8.02% C: 1.0%

respiratory ev aviptadil
Myriad Genetics Delivers Strong Revenue and Earnings Growth in June 2021 Quarter, Continues to Execute on Strategic Growth & Transformation Plans
Published: 2021-08-03 (Crawled : 12:00) - biospace.com/
MYGN | $18.48 -0.11% -0.11% 430K twitter stocktwits trandingview |
Health Technology
| | O: 2.33% H: 11.91% C: 11.56%
CSTL | $19.63 1.66% 1.63% 95K twitter stocktwits trandingview |
Health Technology
| | O: 0.01% H: 1.25% C: 0.85%

genetic ev growth liver
Orthofix Announces First Patient Implant in the M6-C Artificial Cervical Disc Two-Level IDE Study
Published: 2021-08-02 (Crawled : 12:00) - biospace.com/
OFIX | $13.08 -0.15% -0.15% 280K twitter stocktwits trandingview |
Health Technology
| | O: 1.61% H: 1.48% C: -0.6%

implant ev
Xeris Pharmaceuticals Provides Announcement Under the Irish Takeover Rules for Relevant Securities in Issue
Published: 2021-07-29 (Crawled : 21:00) - biospace.com/
XERS | $1.78 2.3% 2.25% 1.3M twitter stocktwits trandingview |
Health Technology
| | O: -0.9% H: 0.9% C: -4.52%

announcement ev
Bioventus and Misonix Announce Definitive Agreement for Bioventus to Acquire MisonixThe Combination Further Differentiates Bioventus’ Product Portfolio and Accelerates Its Revenue Growth
Published: 2021-07-29 (Crawled : 21:00) - biospace.com/
BVS 4 | $4.28 -4.46% -4.67% 140K twitter stocktwits trandingview |
| | O: 0.93% H: 1.91% C: -0.35%
MS | News 0 d | $92.09 1.58% 0.01% 7.3M twitter stocktwits trandingview |
Finance
| | O: 0.09% H: 0.71% C: 0.12%

ev growth
BIOMEDevice Boston Reveals 2021 Center Stage Content
Published: 2021-07-22 (Crawled : 12:00) - biospace.com/
JNJ | News | $149.12 0.82% 0.0% 9.3M twitter stocktwits trandingview |
Health Technology
| | O: -0.08% H: 1.01% C: 0.37%

ev device
Nanopharm and Leyden Labs Announce Agreement to Develop Intranasal Spray Product Candidates for Prophylactic Use Against Known and New Respiratory Viruses
Published: 2021-07-21 (Crawled : 17:00) - biospace.com/
ATR | $140.32 0.7% 0.0% 300K twitter stocktwits trandingview |
Process Industries
| | O: 0.2% H: 0.52% C: -0.9%

nasal spray respiratory ev
Sigilon Therapeutics Appoints Ajay Rai, M.B.A., as Senior Vice President, Head of Business Development
Published: 2021-07-19 (Crawled : 12:00) - biospace.com/
SGTX | $22.47 -2.56% 0.0% 0 twitter stocktwits trandingview |
Health Technology
| | O: -2.0% H: 0.51% C: -1.53%

ev
Pluristem Appoints Prof. Varda Shalev MD and Mr. Doron Birger to Join its Board of Directors
Published: 2021-07-19 (Crawled : 12:00) - biospace.com/
PSTI | $1.0 -2.91% 8.0% twitter stocktwits trandingview |
Health Technology
| | O: -5.18% H: 7.18% C: 3.74%

ev
Autolus Announces Appointment of Edgar Braendle, M.D., Ph.D., as Chief Development Officer
Published: 2021-07-15 (Crawled : 12:00) - biospace.com/
AUTL | $4.58 1.33% 1.31% 1.2M twitter stocktwits trandingview |
Health Technology
| | O: 1.5% H: 0.33% C: -3.29%

ev
Cardiff Oncology Announces the Appointments of Katherine L. Ruffner, M.D., as Chief Medical Officer and James E. Levine as Chief Financial Officer
Published: 2021-07-12 (Crawled : 14:00) - biospace.com/
JNJ | News | $149.12 0.82% 0.0% 9.3M twitter stocktwits trandingview |
Health Technology
| | O: 0.32% H: 0.85% C: -0.15%
CRDF | $4.34 -0.23% -0.23% 460K twitter stocktwits trandingview |
Health Services
| | O: 5.59% H: 0.0% C: -5.87%

ev
Elevar Therapeutics Announces New Appointments to Strengthen its Executive and Senior Leadership Teams
Published: 2021-07-08 (Crawled : 14:00) - biospace.com/
RDUS | $18.17 -1.3% -1.32% 210K twitter stocktwits trandingview |
Health Technology
| | O: -1.63% H: 1.59% C: 0.23%

ev
Ensysce Biosciences Receives Notice of Award for Year Three of Multi-Year NIDA Grant for the Clinical Development of its Next Generation Opioid Products with Overdose Protection
Published: 2021-07-08 (Crawled : 13:15) - biospace.com/
ENSC | $0.551 -3.5% -3.63% 53K twitter stocktwits trandingview |
Health Technology
| | O: 1.28% H: 0.08% C: -0.59%

opioid ev multi-year
Biohaven Announces Preliminary 2Q2021 Net Product Revenue For NURTEC ODT, The First And Only Migraine Medication For Both Acute And Preventive Treatment
Published: 2021-07-07 (Crawled : 12:00) - biospace.com/
BHVN | News 0 d | $38.33 -1.69% -0.03% 1.1M twitter stocktwits trandingview |
Health Technology
| | O: 16.08% H: 2.25% C: -2.18%

treatment migraine ev
Gainers vs Losers
75% 25%

Top 10 Gainers
MTTR | News M | $4.78 174.71% 63.6% 72M twitter stocktwits trandingview |

AGBA | $2.565 105.2% 51.27% 200M twitter stocktwits trandingview |
Finance

MLEC | $2.44 74.29% 42.62% 78M twitter stocktwits trandingview |
n/a

EDBL | News | $6.28 67.02% 40.13% 16M twitter stocktwits trandingview |

ATGL | $2.91 48.81% 32.8% 180K twitter stocktwits trandingview |

ZAPP | $0.2175 47.16% 32.05% 16M twitter stocktwits trandingview |
n/a

ONFO | $0.6075 38.38% 27.74% 7.3M twitter stocktwits trandingview |
n/a

VIVK | $1.48 38.32% 27.7% 530K twitter stocktwits trandingview |
Professional, Scientific, and T...

MNTS | $0.5 35.69% 26.3% 4.8M twitter stocktwits trandingview |

SDIG A | $3.635 35.13% 26.0% 1M twitter stocktwits trandingview |


Your saved searches
Save your searches and get alerts when important news are released.